Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-18

Clinical Trial Update: Trifecta-Kidney cfDNA-MMDx Study

View source ↗

Summary

A University of Alberta-led clinical trial is currently recruiting to evaluate the trifecta-kidney cfDNA-MMDx diagnostic approach for kidney transplant rejectio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Kidney Transplant Rejection | Status: RECRUITING